
OsteoNovus: An orthopedic device company innovating in bone regeneration with biological materials.
Founded with a mission to revolutionize bone regeneration, OsteoNovus is an orthopedic medical device company specializing in the development of biological materials designed to support and regenerate bone. The company's core vision is to provide innovative, effective solutions for orthopedic conditions, enhancing patient outcomes. OsteoNovus offers products that are FDA-cleared, moldable, cohesive, and designed to conform to graft sites while resisting compression and sticking to wet bone, ensuring no-mess removal. Their market focus includes healthcare providers and institutions involved in orthopedic surgery and bone repair.
OsteoNovus has garnered attention from notable figures in the medical and investment communities, contributing to its rapid growth and innovation. Among its key achievements is the successful FDA clearance of its flagship products, which underscores the company's commitment to safety and efficacy. The impact of OsteoNovus extends to improving surgical outcomes and patient recovery times, positioning it as a significant player in the orthopedic medical device industry.

Novum Medical

Osteovantage

Ossio
ossio.io

Osteal Therapeutics
ostealtx.com

OsteoCentric Technologies
osteocentric.com

Molecular Matrix

Bone Health Technologies
bonehealthtech.com

NuOrtho Surgical

RevBio

SpineOvations

Stabiliz Orthopaedics
stabilizortho.com

Bonovo Orthopedics

BioPoly
biopolyortho.com

Atreon Orthopedics
atreonortho.com

Osseon Therapeutics
Companies similar to OsteoNovus include Novum Medical, Osteovantage, Ossio and Osteal Therapeutics.
OsteoNovus was founded in 2013.
OsteoNovus' headquarters is located in Toledo, OH, US.
OsteoNovus' most recent funding round was for $1.3M (USD) in February 2016.
As of Feb 18, 2016, OsteoNovus has raised a total of $1.3M (USD).
OsteoNovus has 11 employees as of Feb 5, 2024.